WIM_22: Effects of Exercise Oncology Intervention in Fitness Capacity and Body Composition in Breast Cancer Survivals

Sponsor
Tigers Running Club (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05882578
Collaborator
(none)
76
1
2
6.6
11.6

Study Details

Study Description

Brief Summary

The goal of this interventional study is to analyze the impact of a supervised oncological exercise intervention in surviving breast cancer patients. The main questions it aims to answer are:

  • Evaluate the efectivity of a supervised individualized and adapted oncological physical exercise program in the cardiovascular fitness of the participants.

  • Analyze the impact of this intervention in the body composition, functionality and quality of life of the parcitipants

Participants will perform a controlled and adapted program, supervised by an especialized professional during 16 weeks.

Researchers will compare this intervention group, where the supervised program will take place, with a control group, where the patients will perform regular physical activity (non-supervised) to see the changes in the efectivity and impact in cardiovascular fitness, body composition and quality of life.

Condition or Disease Intervention/Treatment Phase
  • Other: Oncological physical exercise intervention
  • Other: Active Physical Activities intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
76 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
control trialcontrol trial
Masking:
None (Open Label)
Masking Description:
Doesn´t exist. Patients were allocated depending their preferences
Primary Purpose:
Supportive Care
Official Title:
Effects of Exercise Oncology Intervention in Fitness Capacity and Body Composition in Breast Cancer Survivals
Actual Study Start Date :
Jan 12, 2023
Actual Primary Completion Date :
Apr 9, 2023
Anticipated Study Completion Date :
Jul 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group

Patients will be assessed and screened prior the intervention. After the physical assestment they will attend 2 days a week for the supervised, and controlled sessions of physical exercise, performed in the nature (Retiro park in Madrid). To meassure the intensity of the program, they will use the 1-10 Borg ratio of perceived exertion (RPE).

Other: Oncological physical exercise intervention
An initial physical assestment where clinical history, body composition, functionality, cardiovascular fitness and quality of life will be tested. Patients will be screened and then divided in diferent groups, depending on both their cardiovascular and physical capacity. Then they will perform 2 sessions of combined strength and endurance training per week for 16 weeks. At the end of the training program, the patients will be assesed to evaluate the changes in their cardiovascular fitness, functionality, body composition and quality of life.

Active Comparator: Control Group

Patients will be asked to mantain an active lifestyle, performing physical activity regularly.

Other: Active Physical Activities intervention
An initial physical assestment where clinical history, body composition, functionality, cardiovascular fitness and quality of life will be tested Patients will be suggested to mantain active physical activities in their daily life. At the end of the training program, the patients will be assesed to evaluate the changes in their cardiovascular fitness, functionality, body composition and quality of life.

Outcome Measures

Primary Outcome Measures

  1. Cardiovascular fitness improvement [16 weeks]

    Evaluate the effectiveness of the program in the improvement of the cardiovascular capacity in breast cancer survivors (looking for a difference of 3,49 ml/kg/min of oxigen consumption), using a submaximal cardiovascular test.

Secondary Outcome Measures

  1. Effects in Body composition [16 weeks]

    Analyze the effect of the physical exercise program in the body weight, the body mass index (BMI), percentages in body fat, abdominal fat, fat free mass, bone mass and total body water in patinets that surviuve breast cancer via bioimpedancy

  2. Physical functionality [16 weeks]

    Know the impact of the oncologic physical exercise program in the physical functionality of the patients, using the 6 minutes walk test and the 30 seconds sit and stand test.

  3. Exercise adherence [16 weeks]

    Meassure the level of adherence to the oncologic physical exercise program, registering the assistence to te sessions

  4. Exercise Level [16 weeks]

    Evaluate the effect of the intervention in the level of exercise performed by the patients, using the IPAQ cuesttionaire (short version)

  5. Fatigue levels [16weeks]

    Evaluate the impact of the physical exercise program in the fatigue levels of the participants via the FACT-F questionnaire

  6. Quality of life and health [16 weeks]

    Evaluate the impact of the oncologilcal physical exercise program in the quality of life of the patients in relation with their heath, usint the EQ5D questionnaire.

  7. Anxiety and depression levels [16 weeks]

    Evaluate the impact of the physical oncologic program in the anxiety and depression levels of the subjects using the Hospitalary Anxiety and Depression Scale (HADS)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women diagnosed with primary, type I to III A/B cancer, with hormonal positive (ER+ and PG+), triple positive (ER+, PG+ y HER2+) or triple negative subtype.

  • Women with chemotherapy and radiotherapy phase complete.

  • Women with post-surgery phase complete.

  • Women that are within 5 years from diagnostic.

  • ECOG Score above or equal to 0 or 1.

Exclusion Criteria:
  • Submit medical contraindications to physical exercise by their reference doctor.

  • Women in state IV o methastasis.

  • Pregnant women.

  • Meet any of the criteria of the American Thoracic Society (ATS) to perfrom a cardiovascular fitness test.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tigers Running Club Madrid Spain 28009

Sponsors and Collaborators

  • Tigers Running Club

Investigators

  • Principal Investigator: Soraya Casla-Barrio, PhD, Tigers Running Club
  • Study Chair: Helios Pareja-Galeano, PhD, Universidad Autonoma de Madrid
  • Study Chair: Mónica Castellanos, MSc, Tigers Running Club
  • Study Chair: Jaime Pérez-Vélez, BSc, Tigers Running Club

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Soraya Casla Barrio, PhD in Exercise Pyshiology, Tigers Running Club
ClinicalTrials.gov Identifier:
NCT05882578
Other Study ID Numbers:
  • WIM_SURVIVALS_22
First Posted:
May 31, 2023
Last Update Posted:
May 31, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Soraya Casla Barrio, PhD in Exercise Pyshiology, Tigers Running Club
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 31, 2023